PI3K Inhibitors

LENIOLISIB treats activated phosphoinositide 3-kinase delta syndrome (APDS). It works by balancing substances in your body that help regulate the immune system. This helps your body make mature white blood cells, which protect your body from infection.

ALPELISIB treats symptoms of PIK3CA-related overgrowth spectrum (PROS), a group of conditions that cause extra tissue growth in different parts of the body. It works by blocking a protein that causes cells to grow and multiply. This helps to slow tissue growth.

COPANLISIB treats lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

DUVELISIB treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

Itovebi is part of the PI3K Inhibitors class and treats Breast Cancer. PI3K inhibitors are used to treat certain blood cancers, breast cancers, as well as certain rare genetic disorders. They work by blocking certain PI3K proteins, which helps slow disease progression. Itovebi is only available as a brand name drug.

ALPELISIB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

IDELALISIB treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.